Business

This Mexican town will soon cultivate medicinal cannabis

Mexico’s Ministry of Science, Technology, and Innovation have proposed to allocate the space in a field in the town of Angel Gallardo in the province of Santa Fe for the cultivation of medicinal cannabis. A government official said that the cultivation of medicinal cannabis will be used for the research of refractory epilepsy, saying that “only for this disease is cannabis legal in our country.”

With the firm intention of advancing the cultivation cannabis for medicinal purposes, the government of the province of Santa Fe signed an agreement with Inta for the import of seeds of this plant.

The Ministry of Science, Technology, and Innovation proposed a field in Santa Fe’s town of Angel Gallardo, near the provincial capital. It extends to a property belonging to Inta. Previous tests had been made with other crops.

“We are advancing in what the norms allow us. National law permitted us to come to a signing of an agreement with Inta to request that we be allowed to import the seeds,” said the Minister of Science of Santa Fe, Erica Hynes, in statements to the newspaper UNO of Santa Fe.

Easily monitored, good for cultivation

The province obtained authorization. These “are complex.” Hynes commented that it is not easy to determine the property where planting could take place since it has to be watched and monitored.

Because of this, the chosen spaces are monitored. They are also “suitable for cultivation.

A specific location is yet to be determined. Hynes said, “In principle, our idea is to do it in a property of Angel Gallardo. This previously made other types of crops. But it will be up to the people of Inta who have a lot of land in the province.”

Yet more work

She clarified, “The advances are not as fast as we would like. The (provincial) law was approved unanimously. However, it was a milestone at the national level and had created many expectations for us.”

The cultivation of medicinal marijuana will be used for conditions like refractory epilepsy. (Source)

The minister warned: “We see that there are advances and setbacks, and there is not a clear decision. Moreover, a direction, a north, that we in Santa Fe want to have.”

The official further explained that the planned cultivation and research would be specialized. “Only for this disease is cannabis cultivation legal in our country. Although they are not so many cases, they are important. For each family, it is very painful,” Hynes said.

Making a case for Santa Fe

Meanwhile, the technical capacities needed for the project are already in the province. Specifically, they are in the faculties of the national universities of Rosario and Litoral, in Conicet Santa Fe, Rosario, and the Pharmaceutical Industrial Laboratory (LIF) itself.

Hynes also stressed the difference of the Santa Fe project to the one in the northern province of the country. “Jujuy wants to import (seeds) for commercial purposes, to make drugs for a multinational company. In Santa Fe, we don’t want to do business with a multinational. What the law tells us, our own provincial law, is that the LIF of the province takes charge to resolve the public health issue.”

Self-cultivation option

Finally, she mentioned people who opt for self-cultivation. She said, “The advantage is availability, immediacy,”

“However, it is not legal. People are at the mercy of how the law is interpreted or whatever is going to happen. It will also depend on the expertise of each person to extract the oil and dose it correctly. Today, not only is the practice is illegal, mistakes can be made.”

First published in La Capital, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although the author made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the content provided on this website. Any person or entity relying on the translations does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

Michael Jermaine Cards

Michael Jermaine Cards is a business executive and a financial journalist, with a focus on IT, innovation and transportation, as well as crypto and AI. He writes about robotics, automation, deep learning, multimodal transit, among others. He updates his readers on the latest market developments, tech and CBD stocks, and even the commodities industry. He does management consulting parallel to his writing, and has been based in Singapore for the past 15 years.

Recent Posts

Women Represent 61% of Home Cannabis Growers in the U.S.

A survey found that women comprise 61% of home cannabis growers, marking a diversion from…

10 hours ago

Denmark Proposes Making Its Medical Cannabis Program Permanent

Denmark plans to make its pilot medical cannabis program permanent following its success in treating…

1 day ago

Polish Lawmakers Petition Donald Tusk for Cannabis Decriminalization

Polish lawmakers have submitted a non-binding petition to Prime Minister Donald Tusk, urging cannabis decriminalization…

1 week ago

The UK Medical Cannabis Market: Growth, Diversification, and Opportunities

The UK medical cannabis market has rapidly grown since legalization in 2018, with private actors…

1 week ago

Alcohol & Cannabis: 60% of Cannabis Users Say It Helps Them Drink Less

A new study involving over 23,000 participants in New Zealand found that 60% of people…

1 week ago

French Interior and Justice Ministers Announce Measures to Combat Organized Crime

The French Ministers of the Interior and Justice announced a comprehensive plan to tackle organized…

2 weeks ago